Jeff Fischer, MBA, president of Longhorn Vaccines and Diagnostics, examines how upstream activations in the gut microbiome can be utilised to tackle therapeutic targets. The microbiome has become a catch‑all explanation for everything from obesity to depression, but it can obscure a simpler and more actionable idea: that living microbes matter, but what they shed matters too. Every day the intestinal tract contains a dense ecosystem […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!